Back to Search Start Over

A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function.

Authors :
Fagan V
Johansson C
Gileadi C
Monteiro O
Dunford JE
Nibhani R
Philpott M
Malzahn J
Wells G
Faram R
Cribbs AP
Halidi N
Li F
Chau I
Greschik H
Velupillai S
Allali-Hassani A
Bennett J
Christott T
Giroud C
Lewis AM
Huber KVM
Athanasou N
Bountra C
Jung M
Schüle R
Vedadi M
Arrowsmith C
Xiong Y
Jin J
Fedorov O
Farnie G
Brennan PE
Oppermann U
Source :
Journal of medicinal chemistry [J Med Chem] 2019 Oct 24; Vol. 62 (20), pp. 9008-9025. Date of Electronic Publication: 2019 Oct 15.
Publication Year :
2019

Abstract

Modifications of histone tails, including lysine/arginine methylation, provide the basis of a "chromatin or histone code". Proteins that contain "reader" domains can bind to these modifications and form specific effector complexes, which ultimately mediate chromatin function. The spindlin1 (SPIN1) protein contains three Tudor methyllysine/arginine reader domains and was identified as a putative oncogene and transcriptional coactivator. Here we report a SPIN1 chemical probe inhibitor with low nanomolar in vitro activity, exquisite selectivity on a panel of methyl reader and writer proteins, and with submicromolar cellular activity. X-ray crystallography showed that this Tudor domain chemical probe simultaneously engages Tudor domains 1 and 2 via a bidentate binding mode. Small molecule inhibition and siRNA knockdown of SPIN1, as well as chemoproteomic studies, identified genes which are transcriptionally regulated by SPIN1 in squamous cell carcinoma and suggest that SPIN1 may have a role in cancer related inflammation and/or cancer metastasis.

Details

Language :
English
ISSN :
1520-4804
Volume :
62
Issue :
20
Database :
MEDLINE
Journal :
Journal of medicinal chemistry
Publication Type :
Academic Journal
Accession number :
31550156
Full Text :
https://doi.org/10.1021/acs.jmedchem.9b00562